DietPillsLab
DietPillsLab BMI Calculator
DietPillsLab Calorie Counter
DietPillsLab Calorie Calculator
DietPillsLab Cholesterol
DietPillsLab Diet Pills
DietPillsLab Diabetes
DietPillsLab Weight Loss
DietPillsLab
Home About Us nutrition Eating Disorder Disclaimer Contact Us Blog
DietPillsLab
DietPillsLab Weight Loss PILLS
DietPillsLab Weight Loss Programs
DietPillsLab About Us
DietPillsLab Articles
DietPillsLab Obesity
 
News
 
Facts pertaining to Alli diet pill intake!
Alli, known to be a weight loss drug consists of Xenical which is responsible for cutting extra fat in obese people. Alli, dubbed Orlistat got approved in the year 1999 as a prescription drug to treat severe obesity. It is one of the diet pills which is FDA approved and attempts to reduce weight by decreasing absorption of fat by the intestines.
Read More...
EU supports EMEA to extend indications for Acomplia
Riding on the roller coaster, Acomplia is making good advances as the European Commission endorsed the positive opinion of the European Medicines Evaluation Agency (EMEA) for Acomplia (rimonabant) to include type 2 diabetes trial results in the European Label.
Read More...
GlaxoSmithKline Hands WCRS £30m Weight Loss Pill Account
GlaxoSmithKline’s weight loss pill Alli is selling like a hot cake. In their next stride, GlaxoSmithKline has appointed WCRS to handle the £30m advertising for the pan-European launch of its weight loss ‘wonder-drug' Alli.
Read More...
Sanofi-Aventis prompt response to Lancet Report on Acomplia
Concerned by the Lancet report and a similar report that appeared this week in the British Medical Journal, Acomplia’s manufacturer Sanofi-aventis leaped out a statement on Nov.16th responding to the stories.
Read More...
Glaxo Sells 2 Million Starter Kits of Diet Pill Alli
Since Alli hit shelves in June, two million starter kits of this first over-the-counter weight loss pill were sold in the five months, GlaxoSmithKline said.
Read More...
Get A New Slim Look With Acomplia
Acomplia — manufactured by Sanofi-Aventis — is proving effective and safe in weight loss treatment. In a recent study, it reported that 39% of patients, after the first year of treatment, taking high-dose Acomplia were able to reach a goal of losing 10% of their weight.
Read More...
Prohibited Diet Pill Loaded With Drug Resurfaces
Amphetamine-fortified Brazilian diet pills which were banished by U.S. regulators a year ago likely to have resurfaced in South Florida under a new name.
Read More...
Alli is going strong in the market
Alli -- manufactured by GlaxoSmithKline -- is a less potent form of the prescription drug orlistat. The drug orlistat was marketed under the trade name Xenical by Roche Holding, which had limited success on the market.
Read More...
Copies of Diet Drug Acomplia (Rimonabant) gaining popularity in India
Sanofi-Aventis' Diet drug Acomplia (rimonabant) is getting quite good responses at Indian pharmacies. According to reports from the Indian media, Acomplia in generic form is being sold without a prescription for as little as 12 cents.
Read More...
Diet Pill Rimonabant is all set to make impact
Growing number of overweight individuals are not happy with the performance of over-the-counter diet pills alli. As a result, alli is not getting substantial positive response and it's disappearing
Read More...
Diet drug Alli officially sanctioned to be sold over-the-counter
The exciting news for million of over weight Americans and Europeans is that now the drug Alli- big breakthrough in obesity treatment.
Read More...
Alli is on a new high.
It's good news for GlaxoSmithKline's diet pill alli as its rival competitors Sanofi's Accomplia will not be sold in the market for the time being.
Read More...
 
DietPillsLab
DietPillsLab